Atossa Therapeutics's total assets for Q4 2024 were $76.44M, a decrease of -3.82% from the previous quarter. ATOS total liabilities were $4.97M for the fiscal quarter, a -14.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.